Re: "Strategic Partnership"? pautaotzu

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

milestone

Rank: President [?]

Points: 18650 [?]

Votes: 158 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: "Strategic Partnership"? pautaotzu

posted on Jan 23, 2008 11:23AM

TPL could offer the retail shareholder 500% times the current pps.

5 x .40 = $2/sh

So, it's not a strategic partnership, it's TPL buying the 50% of PDS that they don't hold. The problem with that is that there is no valuation as to the benefit of the strategic partnership to TPL.

I don't think any court in Delaware would see a problem with that offer.

$2 per share for PTSC's 50% of PDS values PDS @ $1.6bn. I'm sure that there are many who could persuade the Delaware Chancery Court that that substantially undervalues PDS, more so with full discovery.